183 related articles for article (PubMed ID: 34500796)
21. Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity.
Mehrpouri M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M; Bashash D
Eur J Pharmacol; 2020 May; 875():173050. PubMed ID: 32142770
[TBL] [Abstract][Full Text] [Related]
22. Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB.
Vielma SA; Krings G; Lopes-Virella MF
Circ Res; 2003 May; 92(10):1130-7. PubMed ID: 12714566
[TBL] [Abstract][Full Text] [Related]
23. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
[TBL] [Abstract][Full Text] [Related]
24. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.
Portale F; Cricrì G; Bresolin S; Lupi M; Gaspari S; Silvestri D; Russo B; Marino N; Ubezio P; Pagni F; Vergani P; Kronnie GT; Valsecchi MG; Locatelli F; Rizzari C; Biondi A; Dander E; D'Amico G
Haematologica; 2019 Mar; 104(3):533-545. PubMed ID: 30262563
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo R; Chen Y; Wang Z; Ma W; Zhang M; Spaeth EL; Wang Y; Battula VL; Mak PY; Schallmoser K; Ruvolo P; Schober WD; Shpall EJ; Nguyen MH; Strunk D; Bueso-Ramos CE; Konoplev S; Davis RE; Konopleva M; Andreeff M
Blood; 2014 Apr; 123(17):2691-702. PubMed ID: 24599548
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re-sensitization by JNK inhibition.
Nicholson L; Evans CA; Matheson E; Minto L; Keilty C; Sanichar M; Case M; Schwab C; Williamson D; Rainer J; Harrison CJ; Kofler R; Hall AG; Redfern CP; Whetton AD; Irving JA
Br J Haematol; 2015 Nov; 171(4):595-605. PubMed ID: 26310606
[TBL] [Abstract][Full Text] [Related]
27. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
28. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways.
Minami T; Abid MR; Zhang J; King G; Kodama T; Aird WC
J Biol Chem; 2003 Feb; 278(9):6976-84. PubMed ID: 12493764
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
30. Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C.
Das KC; White CW
J Biol Chem; 1997 Jun; 272(23):14914-20. PubMed ID: 9169462
[TBL] [Abstract][Full Text] [Related]
31. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
32. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia.
George AA; Paz H; Fei F; Kirzner J; Kim YM; Heisterkamp N; Abdel-Azim H
PLoS One; 2015; 10(9):e0137917. PubMed ID: 26360058
[TBL] [Abstract][Full Text] [Related]
33. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
Lu Y; Jamieson L; Brasier AR; Fields AP
Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
[TBL] [Abstract][Full Text] [Related]
34. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
35. Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?
Steinbach D; Friedrich J; Dawczynski K; Furchtbar S; Gruhn B; Wittig S; Zintl F; Sauerbrey A
Leuk Lymphoma; 2005 Sep; 46(9):1357-63. PubMed ID: 16109615
[TBL] [Abstract][Full Text] [Related]
36. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
37. NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Woon ST; Zwain S; Schooltink MA; Newth AL; Baguley BC; Ching LM
Eur J Cancer; 2003 May; 39(8):1176-83. PubMed ID: 12736120
[TBL] [Abstract][Full Text] [Related]
38. The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells.
Xia J; Matsuhashi S; Hamajima H; Iwane S; Takahashi H; Eguchi Y; Mizuta T; Fujimoto K; Kuroda S; Ozaki I
J Nutr Biochem; 2012 Dec; 23(12):1668-75. PubMed ID: 22475810
[TBL] [Abstract][Full Text] [Related]
39. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation.
Jamaluddin M; Meng T; Sun J; Boldogh I; Han Y; Brasier AR
Mol Endocrinol; 2000 Jan; 14(1):99-113. PubMed ID: 10628750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]